UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034738
Receipt number R000039605
Scientific Title A Japanese survey of gynecological malignant disease in pregnancy
Date of disclosure of the study information 2018/11/01
Last modified on 2019/11/30 10:40:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Japanese survey of gynecological malignant disease in pregnancy

Acronym

A Japanese survey of gynecological malignant disease in pregnancy

Scientific Title

A Japanese survey of gynecological malignant disease in pregnancy

Scientific Title:Acronym

A Japanese survey of gynecological malignant disease in pregnancy

Region

Japan


Condition

Condition

Cervical and ovarian cancer in pregnancy

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to survey gynecological malignant disease occurring during pregnancy in Japan.

Basic objectives2

Others

Basic objectives -Others

Epidemiologic survey

Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

A Japanese survey of cervical and ovarian cancers in pregnancy

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Between January 2012 and December 2017, the patients who had diagnosed as cervical cancer or ovarian cancer in pregnancy.

Border line tumor of ovarian malignancy.

Key exclusion criteria

CIN 3 in the uterine cervix

Target sample size

500


Research contact person

Name of lead principal investigator

1st name Masaki
Middle name
Last name Mandai

Organization

Kyoto University

Division name

Department of Obstetrics and Gynecology

Zip code

6068507

Address

Shogoin Sakyo-ku, Kyoto, Japan

TEL

0757513269

Email

mandai@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name Kondo
Middle name
Last name Eiji

Organization

Mie University School of Medicine

Division name

Department of Obstetrics and Gynecology

Zip code

5148507

Address

2-174, Edobashi, Tsu-city, Mie, Japan

TEL

059-232-1111

Homepage URL


Email

eijikon@clin.medic.mie-u.ac.jp


Sponsor or person

Institute

Japan Society of Obstetrics and Gynecology Committee on Gynecologic Oncology

Institute

Department

Personal name



Funding Source

Organization

Japan Society of Obstetrics and Gynecology Committee on Gynecologic Oncology

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Mie University School of Medicine

Address

2-174, Edobashi, Tsu-city, Mie, Japan

Tel

0592321111

Email

eijikon@clin.medic.mie-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2018 Year 04 Month 18 Day

Date of IRB


Anticipated trial start date

2018 Year 09 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

observational research


Management information

Registered date

2018 Year 11 Month 01 Day

Last modified on

2019 Year 11 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039605


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name